Back
Sonnet BioTherapeutics Holdings Stock Predictions
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right here
Sell
33
SONN
Sonnet BioTherapeutics Holdings
Last Price:
1.88
Seasonality Move:
-15.89%
7 Day Trial
ALL ACCESS PASS
$
7
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.Sonnet BioTherapeutics Holdings Stock Forecast
-
Is Sonnet BioTherapeutics Holdings Stock Undervalued?
The current Sonnet BioTherapeutics Holdings [SONN] share price is $1.86. The Score for SONN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal. - SONN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Sonnet BioTherapeutics Holdings Stock Go Up Next Year?
Data Unavailable
Sonnet BioTherapeutics Holdings Stock Rating
Data Unavailable
Sonnet BioTherapeutics Holdings Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sonnetbio.com
52-Week Data
52-Week High:
26.40
52-Week Low:
1.08
Prediction Charts
Market Cap:
5.71M
Price in USD:
1.86
Volume:
7.52K
Beta:
0.67
Technical Analysis
SMA50:
1.90
SMA100:
1.71
SMA200:
2.76
52-Wk Change:
-66.17%
Stock Predictions
-
Is Sonnet BioTherapeutics Holdings stock public?
Yes, Sonnet BioTherapeutics Holdings is a publicly traded company. -
What is the Sonnet BioTherapeutics Holdings stock quote today?
The Sonnet BioTherapeutics Holdings stock price is 1.86 USD today. -
How to buy Sonnet BioTherapeutics Holdings stock online?
You can buy Sonnet BioTherapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-16 | 1.80 | 1.67 | 1.87 | 1.65 |
| Apr-17 | 1.72 | 1.70 | 1.73 | 1.70 |
| Apr-18 | 1.70 | 1.75 | 1.78 | 1.70 |
| Apr-19 | 1.79 | 1.82 | 1.89 | 1.77 |
| Apr-22 | 1.77 | 1.70 | 1.78 | 1.69 |
| Apr-23 | 1.70 | 1.78 | 1.84 | 1.66 |
| Apr-24 | 1.79 | 1.85 | 1.85 | 1.75 |
| Apr-25 | 1.79 | 1.76 | 1.79 | 1.72 |
| Apr-26 | 1.77 | 1.77 | 1.80 | 1.73 |
| Apr-29 | 1.78 | 1.78 | 1.78 | 1.75 |
| Apr-30 | 1.77 | 1.77 | 1.78 | 1.73 |
| May-1 | 1.74 | 1.86 | 1.90 | 1.74 |
| May-2 | 1.93 | 1.92 | 1.95 | 1.90 |
| May-3 | 1.97 | 1.86 | 1.97 | 1.81 |
Sonnet BioTherapeutics Holdings Earnings
Data Unavailable
Sonnet BioTherapeutics Holdings Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.07 per share, and a decrease next year of $0.00 per share.
* Sonnet BioTherapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.